List of Tables
Table 1. Global Market Dendritic Cell Cancer Vaccines Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Dendritic Cell Cancer Vaccines Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Dendritic Cell Cancer Vaccines Market Size Share by Region (2018-2023)
Table 4. Global Dendritic Cell Cancer Vaccines Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Dendritic Cell Cancer Vaccines Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Dendritic Cell Cancer Vaccines Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Dendritic Cell Cancer Vaccines Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Dendritic Cell Cancer Vaccines Revenue Market Share by Type (2018-2023)
Table 9. Global Dendritic Cell Cancer Vaccines Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Dendritic Cell Cancer Vaccines Revenue Market Share by Type (2024-2029)
Table 11. North America Dendritic Cell Cancer Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Dendritic Cell Cancer Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Dendritic Cell Cancer Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Dendritic Cell Cancer Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Dendritic Cell Cancer Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Dendritic Cell Cancer Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Dendritic Cell Cancer Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Dendritic Cell Cancer Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Dendritic Cell Cancer Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Dendritic Cell Cancer Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Dendritic Cell Cancer Vaccines Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global Dendritic Cell Cancer Vaccines Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Dendritic Cell Cancer Vaccines Revenue Market Share by Application (2018-2023)
Table 24. Global Dendritic Cell Cancer Vaccines Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Dendritic Cell Cancer Vaccines Revenue Market Share by Application (2024-2029)
Table 26. North America Dendritic Cell Cancer Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Dendritic Cell Cancer Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe Dendritic Cell Cancer Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Dendritic Cell Cancer Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Dendritic Cell Cancer Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Dendritic Cell Cancer Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America Dendritic Cell Cancer Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Dendritic Cell Cancer Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Dendritic Cell Cancer Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Dendritic Cell Cancer Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Dendritic Cell Cancer Vaccines Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Dendritic Cell Cancer Vaccines Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dendritic Cell Cancer Vaccines as of 2022)
Table 39. Date of Key Players Enter into Dendritic Cell Cancer Vaccines Market
Table 40. Global Dendritic Cell Cancer Vaccines Key Players Headquarters and Area Served
Table 41. Dendritic Cell Cancer Vaccines Product Solution and Service
Table 42. Global Dendritic Cell Cancer Vaccines Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. 3M Company Basic Information List
Table 45. 3M Company Description and Business Overview
Table 46. 3M Company Dendritic Cell Cancer Vaccines Products, Services and Solutions
Table 47. Revenue (US$ Million) in Dendritic Cell Cancer Vaccines Business of 3M Company (2018-2023)
Table 48. 3M Company Recent Developments
Table 49. Activarti Basic Information List
Table 50. Activarti Description and Business Overview
Table 51. Activarti Dendritic Cell Cancer Vaccines Products, Services and Solutions
Table 52. Revenue (US$ Million) in Dendritic Cell Cancer Vaccines Business of Activarti (2018-2023)
Table 53. Activarti Recent Developments
Table 54. Argos Therapeutics Basic Information List
Table 55. Argos Therapeutics Description and Business Overview
Table 56. Argos Therapeutics Dendritic Cell Cancer Vaccines Products, Services and Solutions
Table 57. Revenue (US$ Million) in Dendritic Cell Cancer Vaccines Business of Argos Therapeutics (2018-2023)
Table 58. Argos Therapeutics Recent Developments
Table 59. Batavia Bioservices Basic Information List
Table 60. Batavia Bioservices Description and Business Overview
Table 61. Batavia Bioservices Dendritic Cell Cancer Vaccines Products, Services and Solutions
Table 62. Revenue (US$ Million) in Dendritic Cell Cancer Vaccines Business of Batavia Bioservices (2018-2023)
Table 63. Batavia Bioservices Recent Developments
Table 64. Bellicum Pharmaceuticals Basic Information List
Table 65. Bellicum Pharmaceuticals Description and Business Overview
Table 66. Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccines Products, Services and Solutions
Table 67. Revenue (US$ Million) in Dendritic Cell Cancer Vaccines Business of Bellicum Pharmaceuticals (2018-2023)
Table 68. Bellicum Pharmaceuticals Recent Developments
Table 69. Creagene Basic Information List
Table 70. Creagene Description and Business Overview
Table 71. Creagene Dendritic Cell Cancer Vaccines Products, Services and Solutions
Table 72. Revenue (US$ Million) in Dendritic Cell Cancer Vaccines Business of Creagene (2018-2023)
Table 73. Creagene Recent Developments
Table 74. DanDrit Biotech Basic Information List
Table 75. DanDrit Biotech Description and Business Overview
Table 76. DanDrit Biotech Dendritic Cell Cancer Vaccines Products, Services and Solutions
Table 77. Revenue (US$ Million) in Dendritic Cell Cancer Vaccines Business of DanDrit Biotech (2018-2023)
Table 78. DanDrit Biotech Recent Developments
Table 79. DCPrime Basic Information List
Table 80. DCPrime Description and Business Overview
Table 81. DCPrime Dendritic Cell Cancer Vaccines Products, Services and Solutions
Table 82. Revenue (US$ Million) in Dendritic Cell Cancer Vaccines Business of DCPrime (2018-2023)
Table 83. DCPrime Recent Developments
Table 84. Sanpower Corporation Basic Information List
Table 85. Sanpower Corporation Description and Business Overview
Table 86. Sanpower Corporation Dendritic Cell Cancer Vaccines Products, Services and Solutions
Table 87. Revenue (US$ Million) in Dendritic Cell Cancer Vaccines Business of Sanpower Corporation (2018-2023)
Table 88. Sanpower Corporation Recent Developments
Table 89. Elios Therapeutics Basic Information List
Table 90. Elios Therapeutics Description and Business Overview
Table 91. Elios Therapeutics Dendritic Cell Cancer Vaccines Products, Services and Solutions
Table 92. Revenue (US$ Million) in Dendritic Cell Cancer Vaccines Business of Elios Therapeutics (2018-2023)
Table 93. Elios Therapeutics Recent Developments
Table 94. ImmunoCellular Therapeutics Basic Information List
Table 95. ImmunoCellular Therapeutics Description and Business Overview
Table 96. ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccines Products, Services and Solutions
Table 97. Revenue (US$ Million) in Dendritic Cell Cancer Vaccines Business of ImmunoCellular Therapeutics (2018-2023)
Table 98. ImmunoCellular Therapeutics Recent Developments
Table 99. Immunicum Basic Information List
Table 100. Immunicum Description and Business Overview
Table 101. Immunicum Dendritic Cell Cancer Vaccines Products, Services and Solutions
Table 102. Revenue (US$ Million) in Dendritic Cell Cancer Vaccines Business of Immunicum (2018-2023)
Table 103. Immunicum Recent Developments
Table 104. Kiromic Basic Information List
Table 105. Kiromic Description and Business Overview
Table 106. Kiromic Dendritic Cell Cancer Vaccines Products, Services and Solutions
Table 107. Revenue (US$ Million) in Dendritic Cell Cancer Vaccines Business of Kiromic (2018-2023)
Table 108. Kiromic Recent Developments
Table 109. Medigene Basic Information List
Table 110. Medigene Description and Business Overview
Table 111. Medigene Dendritic Cell Cancer Vaccines Products, Services and Solutions
Table 112. Revenue (US$ Million) in Dendritic Cell Cancer Vaccines Business of Medigene (2018-2023)
Table 113. Medigene Recent Developments
Table 114. Merck Basic Information List
Table 115. Merck Description and Business Overview
Table 116. Merck Dendritic Cell Cancer Vaccines Products, Services and Solutions
Table 117. Revenue (US$ Million) in Dendritic Cell Cancer Vaccines Business of Merck (2018-2023)
Table 118. Merck Recent Developments
Table 119. Northwest Biotherapeutics Basic Information List
Table 120. Northwest Biotherapeutics Description and Business Overview
Table 121. Northwest Biotherapeutics Dendritic Cell Cancer Vaccines Products, Services and Solutions
Table 122. Revenue (US$ Million) in Dendritic Cell Cancer Vaccines Business of Northwest Biotherapeutics (2018-2023)
Table 123. Northwest Biotherapeutics Recent Developments
Table 124. Glaxo Smith Kline Basic Information List
Table 125. Glaxo Smith Kline Description and Business Overview
Table 126. Glaxo Smith Kline Dendritic Cell Cancer Vaccines Products, Services and Solutions
Table 127. Revenue (US$ Million) in Dendritic Cell Cancer Vaccines Business of Glaxo Smith Kline (2018-2023)
Table 128. Glaxo Smith Kline Recent Developments
Table 129. Tellaorporation Basic Information List
Table 130. Tellaorporation Description and Business Overview
Table 131. Tellaorporation Dendritic Cell Cancer Vaccines Products, Services and Solutions
Table 132. Revenue (US$ Million) in Dendritic Cell Cancer Vaccines Business of Tellaorporation (2018-2023)
Table 133. Tellaorporation Recent Developments
Table 134. Vaxil BioTherapeutics Basic Information List
Table 135. Vaxil BioTherapeutics Description and Business Overview
Table 136. Vaxil BioTherapeutics Dendritic Cell Cancer Vaccines Products, Services and Solutions
Table 137. Revenue (US$ Million) in Dendritic Cell Cancer Vaccines Business of Vaxil BioTherapeutics (2018-2023)
Table 138. Vaxil BioTherapeutics Recent Developments
Table 139. North America Dendritic Cell Cancer Vaccines Market Size by Country (2018-2023) & (US$ Million)
Table 140. North America Dendritic Cell Cancer Vaccines Market Size by Country (2024-2029) & (US$ Million)
Table 141. Europe Dendritic Cell Cancer Vaccines Market Size by Country (2018-2023) & (US$ Million)
Table 142. Europe Dendritic Cell Cancer Vaccines Market Size by Country (2024-2029) & (US$ Million)
Table 143. Asia-Pacific Dendritic Cell Cancer Vaccines Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 144. Asia-Pacific Dendritic Cell Cancer Vaccines Market Size by Region (2018-2023) & (US$ Million)
Table 145. Asia-Pacific Dendritic Cell Cancer Vaccines Market Size by Region (2024-2029) & (US$ Million)
Table 146. Asia-Pacific Dendritic Cell Cancer Vaccines Market Share by Region (2018-2023)
Table 147. Asia-Pacific Dendritic Cell Cancer Vaccines Market Share by Region (2024-2029)
Table 148. Latin America Dendritic Cell Cancer Vaccines Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 149. Latin America Dendritic Cell Cancer Vaccines Market Size by Country (2018-2023) & (US$ Million)
Table 150. Latin America Dendritic Cell Cancer Vaccines Market Size by Country (2024-2029) & (US$ Million)
Table 151. Middle East & Africa Dendritic Cell Cancer Vaccines Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 152. Middle East & Africa Dendritic Cell Cancer Vaccines Market Size by Country (2018-2023) & (US$ Million)
Table 153. Middle East & Africa Dendritic Cell Cancer Vaccines Market Size by Country (2024-2029) & (US$ Million)
Table 154. Dendritic Cell Cancer Vaccines Market Trends
Table 155. Dendritic Cell Cancer Vaccines Market Drivers
Table 156. Dendritic Cell Cancer Vaccines Market Challenges
Table 157. Dendritic Cell Cancer Vaccines Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Dendritic Cell Cancer Vaccines Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Dendritic Cell Cancer Vaccines Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Dendritic Cell Cancer Vaccines Market Share by Regions: 2022 VS 2029
Figure 4. Global Dendritic Cell Cancer Vaccines Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Dendritic Cell Cancer Vaccines Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Dendritic Cell Cancer Vaccines Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Dendritic Cell Cancer Vaccines Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Dendritic Cell Cancer Vaccines Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Dendritic Cell Cancer Vaccines Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of CreaVax
Figure 11. Global CreaVax Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of Sipuleucel-T (Provenge)
Figure 13. Global Sipuleucel-T (Provenge) Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Product Picture of Others
Figure 15. Global Others Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 16. Global Dendritic Cell Cancer Vaccines Market Size Share by Type: 2022 & 2029
Figure 17. North America Dendritic Cell Cancer Vaccines Revenue Market Share by Type (2018-2029)
Figure 18. Europe Dendritic Cell Cancer Vaccines Revenue Market Share by Type (2018-2029)
Figure 19. Asia-Pacific Dendritic Cell Cancer Vaccines Revenue Market Share by Type (2018-2029)
Figure 20. Latin America Dendritic Cell Cancer Vaccines Revenue Market Share by Type (2018-2029)
Figure 21. Middle East and Africa Dendritic Cell Cancer Vaccines Revenue Market Share by Type (2018-2029)
Figure 22. Pediatrics Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 23. Adults Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 24. Global Dendritic Cell Cancer Vaccines Market Size Share by Application: 2022 & 2029
Figure 25. North America Dendritic Cell Cancer Vaccines Revenue Market Share by Application (2018-2029)
Figure 26. Europe Dendritic Cell Cancer Vaccines Revenue Market Share by Application (2018-2029)
Figure 27. Asia-Pacific Dendritic Cell Cancer Vaccines Revenue Market Share by Application (2018-2029)
Figure 28. Latin America Dendritic Cell Cancer Vaccines Revenue Market Share by Application (2018-2029)
Figure 29. Middle East and Africa Dendritic Cell Cancer Vaccines Revenue Market Share by Application (2018-2029)
Figure 30. Dendritic Cell Cancer Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 31. Global Top 5 and Top 10 Players Dendritic Cell Cancer Vaccines Market Share in 2022
Figure 32. North America Dendritic Cell Cancer Vaccines Market Share by Country (2018-2029)
Figure 33. U.S. Dendritic Cell Cancer Vaccines Market Size (2018-2029) & (US$ Million)
Figure 34. Canada Dendritic Cell Cancer Vaccines Market Size (2018-2029) & (US$ Million)
Figure 35. Germany Dendritic Cell Cancer Vaccines Market Size (2018-2029) & (US$ Million)
Figure 36. France Dendritic Cell Cancer Vaccines Market Size (2018-2029) & (US$ Million)
Figure 37. U.K. Dendritic Cell Cancer Vaccines Market Size (2018-2029) & (US$ Million)
Figure 38. Italy Dendritic Cell Cancer Vaccines Market Size (2018-2029) & (US$ Million)
Figure 39. Russia Dendritic Cell Cancer Vaccines Market Size (2018-2029) & (US$ Million)
Figure 40. Nordic Countries Dendritic Cell Cancer Vaccines Market Size (2018-2029) & (US$ Million)
Figure 41. Asia-Pacific Dendritic Cell Cancer Vaccines Market Share by Region (2018-2029)
Figure 42. China Dendritic Cell Cancer Vaccines Market Size (2018-2029) & (US$ Million)
Figure 43. Japan Dendritic Cell Cancer Vaccines Market Size (2018-2029) & (US$ Million)
Figure 44. South Korea Dendritic Cell Cancer Vaccines Market Size (2018-2029) & (US$ Million)
Figure 45. Southeast Asia Dendritic Cell Cancer Vaccines Market Size (2018-2029) & (US$ Million)
Figure 46. India Dendritic Cell Cancer Vaccines Market Size (2018-2029) & (US$ Million)
Figure 47. Australia Dendritic Cell Cancer Vaccines Market Size (2018-2029) & (US$ Million)
Figure 48. Latin America Dendritic Cell Cancer Vaccines Market Share by Country (2018-2029)
Figure 49. Mexico Dendritic Cell Cancer Vaccines Market Size (2018-2029) & (US$ Million)
Figure 50. Brazil Dendritic Cell Cancer Vaccines Market Size (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa Dendritic Cell Cancer Vaccines Market Share by Country (2018-2029)
Figure 52. Turkey Dendritic Cell Cancer Vaccines Market Size (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Dendritic Cell Cancer Vaccines Market Size (2018-2029) & (US$ Million)
Figure 54. UAE Dendritic Cell Cancer Vaccines Market Size (2018-2029) & (US$ Million)
Figure 55. Bottom-up and Top-down Approaches for This Report